Intuitive’s Barten on Europe’s surgical robotics adoption, healthcare shifts & regulatory demands

In this episode of IntuitiveTalks, Dirk Barten, Senior VP and GM of EU Commercial and Marketing at Intuitive, takes us through Europe's unique surgical robotics landscape. He discusses the differences in adoption rates between the US and Europe, where surgical robotics uptake has lagged by about five to seven years. Barten also explains the critical role Intuitive’s digital ecosystem plays in supporting surgeons and healthcare teams throughout Europe. Through tools like tele-education and digital hubs, Intuitive is providing accessible training and data support, which he believes are essential in driving improved patient outcomes and meeting hospitals' needs for more integrated and efficient surgical solutions. In addition, Barten explores how healthcare system consolidation in major European countries is reshaping hospital networks, leading to increased centralization of complex procedures. He highlights Intuitive’s investment in expanding its infrastructure across Europe, with new sites in Switzerland, Germany, and the UK, underscoring Intuitive’s confidence in the region’s growth potential despite ongoing economic pressures. Thank you to Kollmorgen for sponsoring this episode. To learn more about how Kollmorgen works with medical device companies, please visit: www.kollmorgen.com. And that’s not all! Explore some of Kollmorgen’s success stories below: 1. Kollmorgen and Stereotaxis Advance the Precision and Safety of Surgical Robots | https://www.kollmorgen.com/en-us/case-studies/kollmorgen-and-stereotaxis-advance-precision-and-safety-surgical-robots 2. Enabling New Surgical Possibilities with High-Torque, Low-Temperature and Compact-Size Motors | https://www.kollmorgen.com/en-us/case-studies/enabling-new-surgical-possibilities-high-torque-low-temperature-and-compact-size Thank you for listening to the IntuitiveTalks Podcast. Subscribe to the DeviceTalks Podcast Network on every major podcast platform.

There are no comments yet.

Please log in to write the first comment.